Back to results
US 2002/0058667 A1Published application
Compounds specific to adenosine A1 receptors and uses thereof
AssigneeOSI Pharmaceuticals, Inc.
InventorsArlindo L. Castelhano, Bryan McKibben, David J. Witter
Life of this patent
Estimating the term…
Abstract
This invention pertains to compounds which specifically inhibit the adenosine A1 receptor and the use of these compounds to treat a disease associated with A1 adenosine receptors in a subject.
Claims36
A compound having the structure:
- 281
- wherein R2 is a 5-6 membered aromatic ring;
- wherein R3 and R4 are independently H, or alkyl.
A compound having the structure:
- 287
- wherein R2 is a 5-6 membered aromatic ring;
- wherein R3 and R4 are independently H, or alkyl;
- with the proviso that R2 is not 4-pyridyl.
1 more element
A compound having the structure:
- 289
- wherein R2 is a substituted 5-6 membered aromatic ring;
- wherein R3 and R4 are independently H, or alkyl.
A compound having the structure:
- 291
- wherein R2 is a 5-6 membered aromatic ring;
- wherein X is oxygen, or sulfur.
A compound having the structure:
- 293
- wherein R2 is a 5-6 membered aromatic ring;
- wherein X is oxygen, or sulfur.
A method of preparing compounds VI, VII, VIII, IX, or X, comprising the steps of
- a) reacting
- 295
- wherein P is a removable protecting group;
- b) treating the product of step a) under cyclization conditions to provide
- 296
- c) treating the product of step b) under suitable conditions to provide
- 297
- and
- d) treating the chlorinated product of step c) with NH2R1 to provide
- 298
- wherein R1 is 2-(methylamino carbonylamino)-cyclohexyl, acetylamino ethyl, methylamino carbonylamino ethyl, or trans-4-hydroxy cyclohexyl;
- wherein R2 is a four to six membered ring;
- and
- wherein R3 and R4 are independently H, or alkyl.
11 more elements
Dependencies are inferred from the claim text.